Aminopyridines for symptomatic treatment in multiple sclerosis
about
Carnitine for fatigue in multiple sclerosisCarnitine for fatigue in multiple sclerosis4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic reviewFatigue and physical disability in patients with multiple sclerosis: a structural equation modeling approachDisease-modifying therapies in relapsing-remitting multiple sclerosis.Management of fatigue in persons with multiple sclerosis.Treatment of fatigue in multiple sclerosis patients: a neurocognitive approach.Inhibition of neuronal degenerin/epithelial Na+ channels by the multiple sclerosis drug 4-aminopyridine.Molecular mechanisms of inherited demyelinating neuropathies.Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.4-aminopyridine toxicity: a case report and review of the literature.A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.Towards therapeutic applications of arthropod venom k(+)-channel blockers in CNS neurologic diseases involving memory acquisition and storage.Potent block of potassium channels by MEK inhibitor U0126 in primary cultures and brain slices.Dalfampridine (Ampyra): An Aid to Walking in Patients with Multiple Sclerosis.
P2860
Q24197748-7D57FD88-9ED4-49B8-95A2-F03F83F5353EQ24240036-B190D861-0CF2-4FEE-90E1-390008DC1EF7Q27007478-126C5D37-19FF-479C-98A5-76602E2FCBDAQ34098558-2A6C0D75-FE62-428A-9FEC-A1F732B2B74CQ34122924-EC471238-F865-403A-AE25-34312083BDDBQ34180567-2158A01A-917A-4174-BC12-5C6A9C116955Q35390868-CA33BE09-8F8D-4662-9946-FC783C9DAEDFQ36725102-5F4EF02C-43F9-414F-BB88-D68A90849D83Q36942808-4AAA6A57-038A-49B0-B134-C6BC080D1C03Q37594075-8BA581F0-56A8-4A8A-BCF9-7CF7DD3806D0Q38025327-B8F41D7A-9E9B-4AE0-9F6F-768A8BADB769Q38480300-E7F775D3-6929-4DC0-B9A8-ACB52ACECFBDQ42175839-D6278ECF-0341-40AA-9A33-09CA899ECE22Q54976481-5EC2C3D2-508B-4DBF-ADD2-7AA6B4312A45Q55461459-E5371E06-6B82-47D4-AE09-BF8EB8EC9C79
P2860
Aminopyridines for symptomatic treatment in multiple sclerosis
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aminopyridines for symptomatic treatment in multiple sclerosis
@ast
Aminopyridines for symptomatic treatment in multiple sclerosis
@en
Aminopyridines for symptomatic treatment in multiple sclerosis
@nl
type
label
Aminopyridines for symptomatic treatment in multiple sclerosis
@ast
Aminopyridines for symptomatic treatment in multiple sclerosis
@en
Aminopyridines for symptomatic treatment in multiple sclerosis
@nl
prefLabel
Aminopyridines for symptomatic treatment in multiple sclerosis
@ast
Aminopyridines for symptomatic treatment in multiple sclerosis
@en
Aminopyridines for symptomatic treatment in multiple sclerosis
@nl
P2093
P2860
P1476
Aminopyridines for symptomatic treatment in multiple sclerosis
@en
P2093
P2860
P304
P356
10.1002/14651858.CD001330
P407
P577
2001-01-01T00:00:00Z
2002-01-01T00:00:00Z